Literature DB >> 3800453

Adenocarcinoma of the stomach. Changing patterns over the last 4 decades.

W C Meyers, R J Damiano, F S Rotolo, R W Postlethwait.   

Abstract

A retrospective study was performed on 255 consecutive patients admitted to a single hospital from 1953-1983 with a follow-up of 100%. The number of proximal esophagogastric junction and fundus tumors increased significantly over the last 4 decades from 21% to 44% (p less than 0.001), accompanied by a significant decrease in antral carcinomas from 60% to 33% (p less than 0.01). Patients with proximal neoplasms were significantly more likely to be white (71% vs. 29%, p less than 0.001), whereas patients with antral cancer were significantly more likely to be black (64% vs. 36%, p less than 0.001). There were no significant differences in nodal status, presence of distant metastases, or the overall 5-year survival rate between these two sites. The 5-year survival rate for the entire group was 6%. Sixty-five patients (30%) underwent curative resection, and the 5-year survival rate in this group was 24%, which was significantly better than palliative procedures. The 5-year survival rate was strongly influenced by TNM stage, local invasiveness, nodal status, and presence or absence of distal metastases (p less than 0.001). Although the overall survival rate has not changed over the past 30 years, there were definite epidemiologic differences between proximal and antral lesions, which suggest that new treatment protocols should be designed to include the location of the neoplasm.

Entities:  

Mesh:

Year:  1987        PMID: 3800453      PMCID: PMC1492879          DOI: 10.1097/00000658-198701000-00001

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  23 in total

1.  Cancer of the stomach: a review of 854 patients.

Authors:  P Cassell; J O Robinson
Journal:  Br J Surg       Date:  1976-08       Impact factor: 6.939

2.  Time trends of intestinal and diffuse types of gastric cancer in Norway.

Authors:  N Muñoz; J Asvall
Journal:  Int J Cancer       Date:  1971-07-15       Impact factor: 7.396

3.  Epidemiology of cancer of the stomach.

Authors:  S Yamagata; S Hisamichi
Journal:  World J Surg       Date:  1979-11       Impact factor: 3.352

4.  Cancer of the stomach. Review of consecutive ten year intervals.

Authors:  K Adashek; J Sanger; W P Longmire
Journal:  Ann Surg       Date:  1979-01       Impact factor: 12.969

5.  Carcinogenicity test of six nitrosamides and a nitrosocyanamide administered orally to rats.

Authors:  O Bulay; S S Mirvish; H Garcia; A F Pelfrene; B Gold; M Eagen
Journal:  J Natl Cancer Inst       Date:  1979-06       Impact factor: 13.506

6.  Gastric cancer in Colombia. I. Cancer risk and suspect environmental agents.

Authors:  C Cuello; P Correa; W Haenszel; G Gordillo; C Brown; M Archer; S Tannenbaum
Journal:  J Natl Cancer Inst       Date:  1976-11       Impact factor: 13.506

7.  High concentrations of glutathione in glandular stomach: possible implications for carcinogenesis.

Authors:  S C Body; H A Sasame; M R Body
Journal:  Science       Date:  1979-09-07       Impact factor: 47.728

8.  Changes in the location and type of gastric adenocarcinoma.

Authors:  D A Antonioli; H Goldman
Journal:  Cancer       Date:  1982-08-15       Impact factor: 6.860

9.  Gastric cancer. Contemporary aspects.

Authors:  B Cady; D A Ramsden; A Stein; R C Haggitt
Journal:  Am J Surg       Date:  1977-04       Impact factor: 2.565

10.  Bacteria, nitrosamines and cancer of the stomach.

Authors:  M J Hill; G Hawksworth; G Tattersall
Journal:  Br J Cancer       Date:  1973-12       Impact factor: 7.640

View more
  24 in total

1.  Survival in stomach cancer is improving: results of a nationwide population-based Swedish study.

Authors:  L E Hansson; P Sparén; O Nyrén
Journal:  Ann Surg       Date:  1999-08       Impact factor: 12.969

2.  Diagnostic role of serum interleukin-18 in gastric cancer patients.

Authors:  Duangporn Thong-Ngam; Pisit Tangkijvanich; Rungsun Lerknimitr; Varocha Mahachai; Apiradee Theamboonlers; Yong Poovorawan
Journal:  World J Gastroenterol       Date:  2006-07-28       Impact factor: 5.742

3.  Total gastrectomy. Updated operative mortality and long-term survival with particular reference to patients older than 70 years of age.

Authors:  R Bittner; M Butters; M Ulrich; S Uppenbrink; H G Beger
Journal:  Ann Surg       Date:  1996-07       Impact factor: 12.969

Review 4.  Extended lymphadenectomy in gastric cancer: when, for whom and why.

Authors:  D H Roukos
Journal:  Ann R Coll Surg Engl       Date:  1998-01       Impact factor: 1.891

5.  [Gastrectomy de nécessité].

Authors:  R Bittner
Journal:  Langenbecks Arch Chir       Date:  1987

6.  Adjuvant chemoradiotherapy after D2 resection in gastric cancer: a single-center observational study.

Authors:  Esra Kaytan Saglam; Serap Yucel; Emre Balik; Sezer Saglam; Oktar Asoglu; Sumer Yamaner; Dursun Bugra; Ethem N Oral; Ahmet Kizir; Yersu Kapran; Burak Sakar; Ali Akyuz; Mine Gulluoglu
Journal:  J Cancer Res Clin Oncol       Date:  2014-09-05       Impact factor: 4.553

7.  Proximal gastric cancers resected via a transabdominal-only approach. Results and comparisons to distal adenocarcinoma of the stomach.

Authors:  L E Harrison; M S Karpeh; M F Brennan
Journal:  Ann Surg       Date:  1997-06       Impact factor: 12.969

8.  Gastric cancer: a curable disease in Britain.

Authors:  H M Sue-Ling; D Johnston; I G Martin; M F Dixon; M R Lansdown; M J McMahon; A T Axon
Journal:  BMJ       Date:  1993-09-04

9.  A clinicopathological study of gastric cancer with special reference to age of the patients: an analysis of 1,630 cases.

Authors:  T Mitsudomi; T Matsusaka; K Wakasugi; M Takenaka; K Kume; Y Fujinaga; H Teraoka; A Iwashita
Journal:  World J Surg       Date:  1989 Mar-Apr       Impact factor: 3.352

10.  Comparison of chromoendoscopy and conventional endoscopy in the detection of premalignant gastric lesions.

Authors:  Seyed Alireza Taghavi; Mohammed Ebrahim Membari; Ahad Eshraghian; Seyed Moshen Dehghani; Lelah Hamidpour; Farnaz Khademalhoseini
Journal:  Can J Gastroenterol       Date:  2009-02       Impact factor: 3.522

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.